AC Immune Announces Pricing Of Underwritten Offering Of 14.3M Of Its Common Shares At $3.50 per share Common Share, Company Expects Gross Proceeds Of $50.1M
Portfolio Pulse from Benzinga Newsdesk
AC Immune has priced an underwritten offering of 14.3 million of its common shares at $3.50 per share. The company anticipates gross proceeds of approximately $50.1 million from the offering.
December 15, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AC Immune has announced the pricing of its underwritten public offering of 14.3 million common shares at $3.50 each, expecting to raise $50.1 million in gross proceeds.
The announcement of a new share offering typically dilutes existing shareholders, which can lead to a short-term negative impact on the stock price. However, the additional capital raised can be positive if used effectively for growth, R&D, or debt reduction. The exact short-term impact on ACIU's stock price will depend on investor perception of the offering's use of proceeds and market conditions.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100